203 related articles for article (PubMed ID: 25480565)
1. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
[TBL] [Abstract][Full Text] [Related]
3. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
[TBL] [Abstract][Full Text] [Related]
4. The Role of the HLA Class I α2 Helix in Determining Ligand Hierarchy for the Killer Cell Ig-like Receptor 3DL1.
Saunders PM; MacLachlan BJ; Widjaja J; Wong SC; Oates CVL; Rossjohn J; Vivian JP; Brooks AG
J Immunol; 2021 Feb; 206(4):849-860. PubMed ID: 33441440
[TBL] [Abstract][Full Text] [Related]
5. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
Lutz CT
Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.
Grifoni A; Montesano C; Patronov A; Colizzi V; Amicosante M
Biomed Res Int; 2013; 2013():283805. PubMed ID: 23984333
[TBL] [Abstract][Full Text] [Related]
8. Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition.
Saunders PM; Pymm P; Pietra G; Hughes VA; Hitchen C; O'Connor GM; Loiacono F; Widjaja J; Price DA; Falco M; Mingari MC; Moretta L; McVicar DW; Rossjohn J; Brooks AG; Vivian JP
J Exp Med; 2016 May; 213(5):791-807. PubMed ID: 27045007
[TBL] [Abstract][Full Text] [Related]
9. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
Sharma D; Bastard K; Guethlein LA; Norman PJ; Yawata N; Yawata M; Pando M; Thananchai H; Dong T; Rowland-Jones S; Brodsky FM; Parham P
J Immunol; 2009 Oct; 183(7):4569-82. PubMed ID: 19752231
[TBL] [Abstract][Full Text] [Related]
10. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
11. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
Vyas Y; Selvakumar A; Steffens U; Dupont B
Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
13. Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells.
Parsons MS; Zipperlen K; Gallant M; Grant M
J Leukoc Biol; 2010 Nov; 88(5):905-12. PubMed ID: 20664023
[TBL] [Abstract][Full Text] [Related]
14. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
Front Immunol; 2018; 9():1855. PubMed ID: 30147699
[No Abstract] [Full Text] [Related]
15. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
16. KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys.
Schafer JL; Colantonio AD; Neidermyer WJ; Dudley DM; Connole M; O'Connor DH; Evans DT
J Immunol; 2014 Feb; 192(4):1907-17. PubMed ID: 24453246
[TBL] [Abstract][Full Text] [Related]
17. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
Foley BA; De Santis D; Van Beelen E; Lathbury LJ; Christiansen FT; Witt CS
Blood; 2008 Jul; 112(2):435-43. PubMed ID: 18385451
[TBL] [Abstract][Full Text] [Related]
18. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
19. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
